|本期目录/Table of Contents|

[1]李春艳,贺斌峰,王 丹,等.远程监控调节家用无创呼吸机改善COPDⅡ型呼吸衰竭患者症状有效性的分析[J].中华肺部疾病杂志,2020,(05):612-617.[doi:10.3877/cma.j.issn.1674-6902.2020.05.007]
　Li Chunyan,He Binfeng,Wang Dan,et al.Effectiveness of remote monitoring and adjusting non-invasive ventilator to improve the symptoms of COPD patients with type Ⅱ respiratory failure[J].,2020,(05):612-617.[doi:10.3877/cma.j.issn.1674-6902.2020.05.007]
点击复制

远程监控调节家用无创呼吸机改善COPDⅡ型呼吸衰竭患者症状有效性的分析(PDF)

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2020年05期
页码:
612-617
栏目:
论著
出版日期:
2020-10-20

文章信息/Info

Title:
Effectiveness of remote monitoring and adjusting non-invasive ventilator to improve the symptoms of COPD patients with type Ⅱ respiratory failure
作者:
李春艳1; 贺斌峰1; 王 丹1; 甘志新1; 黄朝旺1; 焦玉丁1; 胡明冬1; 2; 徐剑铖1
400037 重庆,陆军(第三)军医大学第二附属医院呼吸与危重症医学中心1 老年与特勤医学科2
Author(s):
Li Chunyan1;  He Binfeng1;  Wang Dan1;  Gan Zhixin1;  Huang Chaowang1;  Jiao Yuding1;  Hu Mingdong1; 2;  Xu Jiancheng1.
1Institute of Respiratory Diseases, Department of Respiratory, Xinqiao Hospita, Army Military Medical University, Chongqing 400037, China; 2Department of Geriatrics and Special Service Medicine, Xinqiao Hospital of the Third Military Medical University, Chongqing 400037, China
关键词:
肺疾病; 慢性阻塞性;  远程监控调节家用无创呼吸机;  临床疗效
Keywords:
Chronic obstructive pulmonary disease;  Remote monitoring and adjusting non-invasive ventilator;  Clinical efficacy
分类号:
R563
DOI:
10.3877/cma.j.issn.1674-6902.2020.05.007
摘要:
目的 分析远程监控调节家用无创呼吸机治疗慢性阻塞性肺疾病(COPD)合并Ⅱ型呼吸衰竭患者的临床疗效。方法 招募70例COPD患者合并Ⅱ型呼吸衰竭的患者,最终入组60例作为研究对象。受试者通过随机数字法分为观察组和对照组,每组30例。观察组辅以远程监控调节家用无创呼吸机进行无创正压通气治疗,对照组给予持续低流量吸氧治疗。两组均予以常规治疗。两组受试者随访1年。比较两组生命体征、动脉血气分析、血清炎性因子、生活质量评分及急性加重次数。结果 CAT评分、mMRC评分、6分钟步行距离(6MWD)、急性加重次数较对照组均有改善(P<0.05)。此外,治疗后两组患者心血氧饱和度(SaO2)、动脉血氧分压(PaO2)、二氧化碳分压(PaCO2)、降钙素原(PCT)、C反应蛋白(CRP)、白介素6(IL-6)、白介素8(IL-8)、肿瘤坏死因子(TNF-α)较对照组均有改善(P<0.05)。结论 远程监控调节家用无创呼吸机促进患者的康复,提高了患者的生活质量。
Abstract:
Objective To evaluate the effect of remote monitoring and adjusting non-invasive ventilator to improve the symptoms of chronic obstructive pulmonary disease(COPD)patients with type Ⅱ respiratory failure. Method All of 70 cases COPD patient with type Ⅱ respiratory failure recruit for this trial and final 60 subjects enrolled in this study. These subjects randomly allocated(1︰1)in the observation group and control group by the random number method. The subjects in the observation group received remote monitoring and adjusting non-invasive ventilator, and the control group received continuous low flow oxygen inhalation. Furthermore, all subjects received COPD therapy. The two groups of subjects were followed up for 1 year and vital signs, arterial blood gas analysis, serum inflammatory factors, quality of life score, and the number of acute exacerbations had been evaluated. Results The CAT score, mMRC score, 6 MWD improved after subjects received remote monitoring and adjusting non-invasive ventilator therapy, compared to the control group(P<0.05). Moreover, the level of SaO2, PaO2, PCT, IL-6, IL-8 and TNF-α decreased in the observation group, compared to the control group(P<0.05). Conclusion Remote monitoring and adjusting non-invasive ventilator effectively improved the symptoms of COPD patients with type Ⅱ respiratory failure, promoted pulmonary rehabilitation of COPD patients.

参考文献/References:

1 任成山, 王关嵩, 钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
2 Klaus FR, Henrik W. Chronic obstructive pulmonary disease[J]. Lancet, 2017, 389(10082): 1931-1940.
3 Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010[J]. Lancet, 2012, 380(9859): 2095-20128.
4 Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories[J]. Lancet, 2018, 392(10159): 2052-2090.
5 Inmaculada A, Pilar de L, Julio A, et al. 10 Years after EPISCAN: A New Study on the Prevalence of COPD in Spain-a Summary of the EPISCAN Ⅱ Protocol[J]. Arch Bronconeumol, 2019, 55(1): 38-47.
6 Miravitlles M, Soler-cataluna JJ, Calle M, et al. Spanish Guidelines for Management of Chronic Obstructive Pulmonary Disease GESEPOC 2017.Pharmacological Treatment of Stable Phase[J]. Arch Bronconeumol, 2017, 53(6): 324-335.
7 Pleguezuelos E,Gimeno SE, Hernandez C, et al. Recommendations on non-pharmacological Treatment in Chronic Obstructive Pulmonary Disease From the Spanish COPD Guidelines(GESEPOC 2017)[J]. Arch Bronconeumol, 2018, 54(11): 568-575.
8 Sietske van der L, Marieke LD. High-intensity non-invasive ventilation in stable hypercapnic COPD: evidence of efficacy and practical advice[J]. Respirology, 2019, 24(4): 318-328.
9 Ram FSM, Picot J, Lightowler J, et al. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease[J]. Cochrane Database Syst Rev, 2004,(1): CD004104.
10 Vasiliki T, Chaido P, Eleni K, et al. One-year non-invasive ventilation in chronic hypercapnic COPD: Effect on quality of life[J]. Respir Med, 2008, 102(6): 904-911.
11 元 梅, 韩其政, 赵 慧, 等. 家庭无创正压通气对COPD合并呼吸衰竭病人生活质量的影响[J]. 中国老年学杂志, 2012, 32(20): 4561-4563.
12 Holland AE, Spruit MA, Troosters T, et al. An Offificial European Respiratory Society/American Thoracic Society Technical Standard: fifield walking tests in chronic respiratory disease[J]. Eur Respir J, 2014, 44(6): 1428-1246.
13 Hernandes NA, Wouters EF, Meijer K, et al. Reproducibility of 6-minute walking test in patients with COPD[J]. Eur Respir J, 2011, 38(2): 261-267.
14 孙 雅, 张彩莲. 长期家庭无创通气对慢性阻塞性肺疾病应用进展的探析[J]. 世界最新医学信息文摘, 2018, 18(68): 75-76, 84.
15 Barnes PJ. Mediators of chronic obstructive pulmonary disease[J]. Pharm Rev, 2004, 56(4): 515-548.
16 Shahriary A, Ghanei M, Rahmani H. The systemic nature of mustard lung: comparison with COPD patients[J]. Interdiscip Toxicol, 2017, 10(3): 114-127.
17 Castellucci M, Rossato M, Calzetti F, et al. IL-10 disrupts the Brd4-docking sites to inhibit LPS-induced CXCL8 and TNF-α expression in monocytes: implications for chronic obstructive pulmonary disease[J]. J Allergy Clin Immunol, 2015, 136(3): 781-791.
18 Khaled Al-shair, Umme K, Rachel D, et al. Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD[J]. Respir Res, 2011, 12(1): 3.
19 朱幼鸣, 胡 辉, 曾 烨. 无创正压通气辅助治疗对COPD合并Ⅱ型呼吸衰竭患者血气参数、心功能及炎症状态的影响[J]. 海南医学院学报, 2017, 23(3): 327-330.
20 王新杰. 孟鲁司特钠联合BiPAP呼吸机对COPD合并呼吸衰竭患者CRP、TNF-α、NT-proBNP 的影响[J]. 标记免疫分析与临床, 2016, 23(9): 1024-1026.
21 袁一帆, 莫伟良, 袁楚樊. 无创正压通气治疗对COPD合并Ⅱ型呼吸衰竭患者血气参数及炎症状态的影响[J]. 白求恩医学杂志, 2019, 17(2): 147-149.
22 杨东霞, 苏炜欣, 黄晓霞. 无创正压通气+常规治疗在COPD并Ⅱ型呼吸衰竭患者中的应用价值[J]. 中国医学创新, 2019, 16(16): 68-71.
23 周松林, 徐文波. 无创机械通气治疗慢性肺源性心脏病合并Ⅱ型呼吸衰竭的临床疗效[J]. 中国现代医学杂志, 2015, 25(12): 106-109.
24 王春芳, 于耀龙, 赵富栋. 孟鲁司特钠联合双水平气道正压通气呼吸机治疗哮喘-慢性阻塞性肺疾病重叠综合征的效果[J]. 中国临床实用医学, 2018, 9(4): 25-29.
25 赵树凯. 孟鲁司特钠对COPD急性加重期患者肺功能和诱导痰TNF-α、IL-8的影响[J]. 北方药学, 2019, 16(5): 76-77.

备注/Memo

备注/Memo:
基金项目: 军事医学创新工程专项(18CXZ002) 重庆市社会民生科技创新专项项目(cstc2016shmszx130034) 院临床科研课题重点项目(2016YLC06) 通信作者: 徐剑铖, Email: xqxjc@163.com 胡明冬, Email: huhanshandd@163.com
更新日期/Last Update: 2020-10-20